Ascensia Diabetes Care renews Medtronic deal

Ascensia Diabetes Care has announced that it has renewed its contract with Medtronic to develop and market diabetes management devices

Ascensia will continue to exclusively co-develop and supply Contour Next Link and Contour Plus Link blood glucose meters. The meters are wirelessly compatible to communicate with Medtronic’s integrated insulin pump and continuous glucose monitoring (CGM) systems.

Michael Kloss, CEO of Ascensia Diabetes Care, said: “To date we have launched three meter generations with Medtronic MiniMed insulin pump systems across the world and have seen success with this alliance.

Medtronic is leading the path towards the artificial pancreas through their research and development. It is testament to the quality and accuracy of our blood glucose monitoring systems that Medtronic has chosen them as part of their MiniMed insulin pump systems. 

We are delighted to collaborate with Medtronic on future insulin pump systems to simplify and improve the lives of people with diabetes.”

Alejandro Galindo, President of the Intensive Insulin Management Business at Medtronic, said: “Medtronic aims to transform diabetes care around the world through continuous product innovations so that people living with diabetes can enjoy greater freedom and better health. We are excited to continue our strategic alliance with Ascensia as we strive to achieve this goal.”